EMA Issues Guideline on Covariates in Clinical Trials

Drug Industry Daily
Drugmakers planning to assign clinical trial participants to a separate arm of the study based on baseline monitoring must report those plans to the European Medicines Agency, including which factors — called covariates — they plan to rely on to make those assignments.

To View This Article:


Subscribe To Drug Industry Daily